Insights

Innovative R&D FUTRUE GmbH is actively engaged in developing cutting-edge medical technologies, such as novel microelectrode arrays for brain interface applications, indicating a need for advanced hardware, sensor technology, and specialized manufacturing solutions.

Growth in E-Health With a focus on e-health and digital healthcare solutions, FUTRUE is likely to require robust software platforms, data analytics tools, and cloud infrastructure to support its expanding digital health services and drug approval processes.

Global Reach As an internationally oriented healthcare group with multiple subsidiaries, FUTRUE offers opportunities for multinational supply chain solutions, compliance consulting, and regional market expansion services.

Biotech & Pharma Needs The company's focus on microbiome therapies, chemical-free medicines, and innovative pain treatments suggests demand for specialized biotechnology equipment, raw materials, and formulation technologies tailored to emerging pharmaceutical products.

Growth Potential With a revenue range of $25 million to $50 million and several fast-growing subsidiaries, FUTRUE is positioned for significant expansion, creating opportunities for strategic partnerships, investment, and support in scaling manufacturing and R&D capabilities.

Similar companies to FUTRUE

FUTRUE Tech Stack

FUTRUE uses 8 technology products and services including Meta, Salesforce, Microsoft Power Query, and more. Explore FUTRUE's tech stack below.

Meta
Advertising
Salesforce
Customer Relationship Management
Microsoft Power Query
Data Integration
git
Development
Microsoft
Miscellaneous
PHP
Programming Languages
Personio
Recruitment Marketing
WhatsApp
Social Sharing

Media & News

FUTRUE GmbH is developing novel microelectrode array on Mar 31st '26.
With the development of a novel microelectrode array (mikro-ECoG) designed to be placed on the surface of the brain and transmit information directly to specific brain areas, FUTRUE Neurosciences has now completed a key technological step on its journey.
Mar 31, 2026 | www.prleap.com

FUTRUE's Email Address Formats

FUTRUE uses at least 1 format(s):

FUTRUE Email Formats	Example	Percentage
F.Last@futrue.com	J.Doe@futrue.com	97%
First.Last@futrue.com	John.Doe@futrue.com	2%
FL@futrue.com	JD@futrue.com	1%

Frequently Asked Questions

Where is FUTRUE's headquarters located?

FUTRUE's main headquarters is located at 14 am Haag Gräfelfing, Bavaria 82166 Germany. The company has employees across 1 continents, including Europe.

What is FUTRUE's official website and social media links?

FUTRUE's official website is futrue.com and has social profiles on LinkedIn.

What is FUTRUE's NAICS code?

FUTRUE's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does FUTRUE have currently?

As of June 2026, FUTRUE has approximately 263 employees across 1 continents, including Europe. Key team members include Head Of R&d / Regulatory / Quality Assurance: B. B.Founder And Ceo: C. F.Co-Founder And Cso: M. H.. Explore FUTRUE's employee directory with LeadIQ.

What industry does FUTRUE belong to?

FUTRUE operates in the Pharmaceutical Manufacturing industry.

What technology does FUTRUE use?

FUTRUE's tech stack includes MetaSalesforceMicrosoft Power QuerygitMicrosoftPHPPersonioWhatsApp.

What is FUTRUE's email format?

FUTRUE's email format typically follows the pattern of F.Last@futrue.com. Find more FUTRUE email formats with LeadIQ.

When was FUTRUE founded?

FUTRUE was founded in 2008.

FUTRUE

Q: What is FUTRUE's official website and social media links?

FUTRUE's official website is futrue.com. FUTRUE has social profiles on LinkedIn.

Q: How many employees does FUTRUE have currently?

FUTRUE has approximately 263 employees.

Q: What technology does FUTRUE use?

FUTRUE's tech stack includes Tableau, Linux, Nginx, Looker, GitHub Copilot.

Q: What is FUTRUE's NAICS code?

FUTRUE's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingBavaria, Germany201-500 Employees

FUTRUE is more than just an internationally orientated healthcare group! With over 20 companies and more than 90 drug approvals, we are a global leader in areas such as e-health, microbiome therapy, innovative pain therapies and chemical-free medicines. Many of our companies, including SYNformulas and VERTANICAL, are among the fastest growing healthcare companies in the world. In order to continue this success, we rely on a new generation of dynamic talents who have the courage to take unfamiliar paths. Our goal is to give as many people as possible a new lease of life! Do you want to help shape the future? Apply now!